Authors' reply re: Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Inge McM
IM
de Kok
Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Joost
J
van Rosmalen
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Marjolein
M
van Ballegooijen
D003362:Cost-Benefit Analysis; D004247:DNA; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections; D002583:Uterine Cervical Neoplasms
D004247:DNA